Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics
暂无分享,去创建一个
Huijue Jia | Junhua Li | Huanming Yang | Jian Wang | K. Kristiansen | Huanzi Zhong | Bing Chen | L. Madsen | Xun Xu | Yong Hou | Siqi Liu | S. Brix | J. Zi | Yan Gao | Guixue Hou | Fangming Yang | Baojin Zhou | Yue Zhao | Chao Fang | Yi-Heng Hu | Fang Liu | Jun Zhang | Ziyi Yang | Hua Zou | Huahui Ren | Yan Lu | Zhun Shi | Jiegen Wu | Jiayu Chen | Xiao Bao | Karsten Kristiansen | Fang Liu | Yan Lu | Susanne Brix | Jian Wang | Huanming Yang | Xun Xu | Guixue Hou | Ziyi Yang | Yue Zhao | Baojin Zhou | Jiayu Chen | Xiao Bao | Yan Gao | Jun Zhang | Yong Hou | Siqi Liu | Lise Madsen
[1] Junhua Li,et al. Age-dependent sexual dimorphism in the adult human gut microbiota , 2019, bioRxiv.
[2] J. Raes,et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study , 2019, Nature Medicine.
[3] Eddy J. Bautista,et al. Longitudinal multi-omics of host–microbe dynamics in prediabetes , 2019, Nature.
[4] Qiang Feng,et al. 1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses , 2019, Nature Biotechnology.
[5] Q. Tong,et al. Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis , 2019, EBioMedicine.
[6] M. Saad,et al. Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. , 2018, The Journal of nutritional biochemistry.
[7] Rob Knight,et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models , 2018, Nature Medicine.
[8] Timothy R Church,et al. A taxonomic signature of obesity in a large study of American adults , 2018, Scientific Reports.
[9] Patrice D Cani,et al. The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice , 2018, Diabetologia.
[10] Yingli Lu,et al. A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota , 2018, Front. Endocrinol..
[11] Peer Bork,et al. Extensive impact of non-antibiotic drugs on human gut bacteria , 2018, Nature.
[12] Andrew Fagan,et al. Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis. , 2018, JCI insight.
[13] T. R. Licht,et al. Aberrant intestinal microbiota in individuals with prediabetes , 2018, Diabetologia.
[14] Jian Wang,et al. Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing , 2017, GigaScience.
[15] Jian Wang,et al. SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data , 2017, GigaScience.
[16] E. Rimm,et al. Metatranscriptome of human fecal microbial communities in a cohort of adult men , 2018, Nature Microbiology.
[17] C. Huttenhower,et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome , 2018, Nature Microbiology.
[18] Xun Xu,et al. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment , 2017, Nature Communications.
[19] Robert Heyer,et al. Challenges and perspectives of metaproteomic data analysis. , 2017, Journal of biotechnology.
[20] Xun Xu,et al. The gut microbiome in atherosclerotic cardiovascular disease , 2017, Nature Communications.
[21] Huijue Jia,et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention , 2017, Nature Medicine.
[22] Ben C. Collins,et al. Quantitative proteomics: challenges and opportunities in basic and applied research , 2017, Nature Protocols.
[23] Yichong Li,et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013 , 2017, JAMA.
[24] Duy Tin Truong,et al. Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis , 2017, npj Biofilms and Microbiomes.
[25] David Torrents,et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug , 2017, Nature Medicine.
[26] Jian Wang,et al. Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals , 2017, GigaScience.
[27] D. Sacks,et al. Absence of IQGAP1 Protein Leads to Insulin Resistance* , 2017, The Journal of Biological Chemistry.
[28] G. Núñez,et al. Mechanisms of inflammation-driven bacterial dysbiosis in the gut , 2016, Mucosal Immunology.
[29] A. Heintz‐Buschart,et al. Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes , 2016, Nature Microbiology.
[30] P. Bork,et al. Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.
[31] Zesong Li,et al. A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine Proteins. , 2016, Journal of proteome research.
[32] H. Koepsell,et al. Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus , 2016, Expert opinion on therapeutic targets.
[33] Xia Li,et al. APD3: the antimicrobial peptide database as a tool for research and education , 2015, Nucleic Acids Res..
[34] W. D. de Vos,et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice , 2016, Nature Medicine.
[35] Jun Wang,et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota , 2015, Nature.
[36] Jens Roat Kultima,et al. Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2016 .
[37] Rachel M. Adams,et al. Metaproteomics reveals functional shifts in microbial and human proteins during a preterm infant gut colonization case , 2015, Proteomics.
[38] Paul Wilmes,et al. A decade of metaproteomics: Where we stand and what the future holds , 2015, Proteomics.
[39] R. Schnabel,et al. Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes , 2015, Diabetes Care.
[40] R. Heyer,et al. The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation. , 2015, Journal of proteome research.
[41] Guangshun Wang,et al. APD 3 : the antimicrobial peptide database as a tool for research and education , 2015 .
[42] Gillian Dekkers,et al. IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..
[43] Qiang Feng,et al. IQuant: An automated pipeline for quantitative proteomics based upon isobaric tags , 2014, Proteomics.
[44] Jens Roat Kultima,et al. An integrated catalog of reference genes in the human gut microbiome , 2014, Nature Biotechnology.
[45] S. Stowell,et al. Galectin-3 Regulates Desmoglein-2 and Intestinal Epithelial Intercellular Adhesion* , 2014, The Journal of Biological Chemistry.
[46] Jens Roat Kultima,et al. Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2015, Nature.
[47] Fredrik H. Karlsson,et al. Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.
[48] K. Xavier,et al. AI-2-mediated signalling in bacteria. , 2013, FEMS microbiology reviews.
[49] S. Rebuffat. Microcins in action: amazing defence strategies of Enterobacteria. , 2012, Biochemical Society transactions.
[50] M. Blaut,et al. Role of commensal gut bacteria in inflammatory bowel diseases , 2012, Gut microbes.
[51] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[52] P. Austin. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.
[53] J. Wiesner,et al. Antimicrobial peptides: The ancient arm of the human immune system , 2010, Virulence.
[54] Joshua E. Elias,et al. Target-Decoy Search Strategy for Mass Spectrometry-Based Proteomics , 2010, Proteome Bioinformatics.
[55] Markus Brosch,et al. Accurate and sensitive peptide identification with Mascot Percolator. , 2009, Journal of proteome research.
[56] M. Mann,et al. Universal sample preparation method for proteome analysis , 2009, Nature Methods.
[57] Adam Godzik,et al. Shotgun metaproteomics of the human distal gut microbiota , 2008, The ISME Journal.
[58] C. Eyers. Universal sample preparation method for proteome analysis , 2009 .
[59] Max Kuhn,et al. Building Predictive Models in R Using the caret Package , 2008 .
[60] D. James,et al. CaMKII-mediated phosphorylation of the myosin motor Myo1c is required for insulin-stimulated GLUT4 translocation in adipocytes. , 2008, Cell metabolism.
[61] D. Hsu,et al. Galectin-3 Is a Negative Regulator of Lipopolysaccharide-Mediated Inflammation1 , 2008, The Journal of Immunology.
[62] Michael B Wheeler,et al. The Identification of Potential Factors Associated with the Development of Type 2 Diabetes , 2008, Molecular & Cellular Proteomics.
[63] S. Hsu,et al. A dual role for IQGAP1 in regulating exocytosis , 2008, Journal of Cell Science.
[64] G. Graham,et al. Antibacterial actions of secreted phospholipases A2. Review. , 2008, Biochimica et biophysica acta.
[65] Michael Stumvoll,et al. Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.
[66] J. Nielsen,et al. Uncovering transcriptional regulation of metabolism by using metabolic network topology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[67] C. van Weel,et al. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. , 2005, Diabetes care.
[68] J. Pickup. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.
[69] C. Weel,et al. - Glucosidase Inhibitors for Patients With Type 2 Diabetes Results from a Cochrane systematic review and meta-analysis , 2004 .
[70] T. Ley,et al. Normal neutrophil function in cathepsin G-deficient mice. , 1999, Blood.
[71] D. N. Perkins,et al. Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.
[72] J. Duranton,et al. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor. , 1998, Biochemistry.
[73] N. Weatherill,et al. Introduction * , 1947, Nordic Journal of Linguistics.